These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1289500)

  • 1. Pharmacological studies on 3-formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-one (T-614), a novel antiinflammatory agent. 4th communication: inhibitory effect on the production of interleukin-1 and interleukin-6.
    Tanaka K; Aikawa Y; Kawasaki H; Asaoka K; Inaba T; Yoshida C
    J Pharmacobiodyn; 1992 Nov; 15(11):649-55. PubMed ID: 1289500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological studies of the new antiinflammatory agent 3-formylamino-7-methylsulfonylamino-6-phenoxy-4'-1-benzopyran-4-o ne. 2nd communication: effect on the arachidonic acid cascades.
    Tanaka K; Makino S; Shimotori T; Aikawa Y; Inaba T; Yoshida C
    Arzneimittelforschung; 1992 Jul; 42(7):945-50. PubMed ID: 1329779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological studies of the new antiinflammatory agent 3-formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-o ne. 1st communication: antiinflammatory, analgesic and other related properties.
    Tanaka K; Shimotori T; Makino S; Aikawa Y; Inaba T; Yoshida C; Takano S
    Arzneimittelforschung; 1992 Jul; 42(7):935-44. PubMed ID: 1418059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological studies on 3-formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-one (T-614), a novel antiinflammatory agent. 3rd communication: the involvement of bradykinin in its analgesic actions.
    Tanaka K; Shimotori T; Makino S; Eguchi M; Asaoka K; Kitamura R; Yoshida C
    J Pharmacobiodyn; 1992 Nov; 15(11):641-7. PubMed ID: 1289499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-614, a novel antirheumatic drug, inhibits both the activity and induction of cyclooxygenase-2 (COX-2) in cultured fibroblasts.
    Tanaka K; Kawasaki H; Kurata K; Aikawa Y; Tsukamoto Y; Inaba T
    Jpn J Pharmacol; 1995 Apr; 67(4):305-14. PubMed ID: 7650864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cytokine activation processes in vitro by tenidap, a novel anti-inflammatory agent.
    McNiff PA; Laliberte RE; Svensson L; Pazoles CJ; Gabel CA
    Cytokine; 1995 Feb; 7(2):196-208. PubMed ID: 7780040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of E-5110 on interleukin-1 generation from human monocytes.
    Shirota H; Goto M; Hashida R; Yamatsu I; Katayama K
    Agents Actions; 1989 Jun; 27(3-4):322-4. PubMed ID: 2801317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new anti-rheumatic drug, T-614, effectively suppresses the development of autoimmune encephalomyelitis.
    Aikawa Y; Tanuma N; Shin T; Makino S; Tanaka K; Matsumoto Y
    J Neuroimmunol; 1998 Aug; 89(1-2):35-42. PubMed ID: 9726823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel inhibitor of IL-1 generation, E5090: in vitro inhibitory effects on the generation of IL-1 by human monocytes.
    Goto M; Chiba K; Hashida R; Shirota H
    Agents Actions Suppl; 1991; 32():225-9. PubMed ID: 2069091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of prostaglandin H synthase 2 expression in human monocytes by the marine natural products manoalide and scalaradial. Novel effects independent of inhibition of lipid mediator production.
    Glaser KB; Lock YW
    Biochem Pharmacol; 1995 Sep; 50(7):913-22. PubMed ID: 7575673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of L-leucine methyl ester mediated killing of THP-1, a human monocytic cell line, by a new anti-inflammatory drug, T614.
    Sawada T; Hashimoto S; Tohma S; Nishioka Y; Nagai T; Sato T; Ito K; Inoue T; Iwata M; Yamamoto K
    Immunopharmacology; 2000 Sep; 49(3):285-94. PubMed ID: 10996026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of theophylline on the production of interleukin-1 beta, tumor necrosis factor-alpha, and interleukin-8 by human peripheral blood mononuclear cells.
    Yoshimura T; Usami E; Kurita C; Watanabe S; Nakao T; Kobayashi J; Yamazaki F; Nagai H
    Biol Pharm Bull; 1995 Oct; 18(10):1405-8. PubMed ID: 8593446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure of T lymphocytes to leflunomide but not to dexamethasone favors the production by monocytic cells of interleukin-1 receptor antagonist and the tissue-inhibitor of metalloproteinases-1 over that of interleukin-1beta and metalloproteinases.
    Déage V; Burger D; Dayer JM
    Eur Cytokine Netw; 1998 Dec; 9(4):663-8. PubMed ID: 9889411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The analgesic NSAID lornoxicam inhibits cyclooxygenase (COX)-1/-2, inducible nitric oxide synthase (iNOS), and the formation of interleukin (IL)-6 in vitro.
    Berg J; Fellier H; Christoph T; Grarup J; Stimmeder D
    Inflamm Res; 1999 Jul; 48(7):369-79. PubMed ID: 10450786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-1 beta converting enzyme is a target for nitric oxide-releasing aspirin: new insights in the antiinflammatory mechanism of nitric oxide-releasing nonsteroidal antiinflammatory drugs.
    Fiorucci S; Santucci L; Cirino G; Mencarelli A; Familiari L; Soldato PD; Morelli A
    J Immunol; 2000 Nov; 165(9):5245-54. PubMed ID: 11046058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressive effect of hepatitis B virus on the induction of interleukin-1 beta and interleukin-6 gene expression in the THP-1 human monocytic cell line.
    Oquendo J; Dubanchet S; Capel F; Mabit H; Petit MA
    Eur Cytokine Netw; 1996 Dec; 7(4):793-800. PubMed ID: 9010683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin derivative, N-(p-coumaroyl) serotonin, inhibits the production of TNF-alpha, IL-1alpha, IL-1beta, and IL-6 by endotoxin-stimulated human blood monocytes.
    Kawashima S; Hayashi M; Takii T; Kimura H; Zhang HL; Nagatsu A; Sakakibara J; Murata K; Oomoto Y; Onozaki K
    J Interferon Cytokine Res; 1998 Jun; 18(6):423-8. PubMed ID: 9660250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Besifloxacin, a novel fluoroquinolone antimicrobial agent, exhibits potent inhibition of pro-inflammatory cytokines in human THP-1 monocytes.
    Zhang JZ; Ward KW
    J Antimicrob Chemother; 2008 Jan; 61(1):111-6. PubMed ID: 17965029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin effect on interleukin 1 (IL-1) and interleukin 6 (IL-6) production by lipopolysaccharide-stimulated human monocytes.
    Schillaci R; Eugui EM; Roldán A
    Horm Metab Res; 1994 Feb; 26(2):113-5. PubMed ID: 8200613
    [No Abstract]   [Full Text] [Related]  

  • 20. Modulation of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6, interleukin-8, and granulocyte/macrophage colony-stimulating factor expression in human monocytes by an endogenous anxiogenic benzodiazepine ligand, triakontatetraneuropeptide: evidence for a role of prostaglandins.
    Taupin V; Gogusev J; Descamps-Latscha B; Zavala F
    Mol Pharmacol; 1993 Jan; 43(1):64-9. PubMed ID: 8380885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.